The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Eluting Stents(DES) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Drug Eluting Stents(DES) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug Eluting Stents(DES) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Coronary Heart Disease accounting for % of the Drug Eluting Stents(DES) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cobalt-chromium Alloy Stents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drug Eluting Stents(DES) include Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, Biosensors, and Biotronik, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug Eluting Stents(DES) market is split by Materials and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Materials and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Materials, covers
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Market segment by Application can be divided into
Coronary Heart Disease
Clinical
The key market players for global Drug Eluting Stents(DES) market are listed below:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Stents(DES) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Eluting Stents(DES), with price, sales, revenue and global market share of Drug Eluting Stents(DES) from 2019 to 2022.
Chapter 3, the Drug Eluting Stents(DES) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Stents(DES) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Materials and application, with sales market share and growth rate by materials, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug Eluting Stents(DES) market forecast, by regions, materials and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Eluting Stents(DES).
Chapter 13, 14, and 15, to describe Drug Eluting Stents(DES) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Drug Eluting Stents(DES) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug Eluting Stents(DES) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Coronary Heart Disease accounting for % of the Drug Eluting Stents(DES) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cobalt-chromium Alloy Stents segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drug Eluting Stents(DES) include Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, Biosensors, and Biotronik, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug Eluting Stents(DES) market is split by Materials and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Materials and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Materials, covers
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials
Market segment by Application can be divided into
Coronary Heart Disease
Clinical
The key market players for global Drug Eluting Stents(DES) market are listed below:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Stents(DES) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Eluting Stents(DES), with price, sales, revenue and global market share of Drug Eluting Stents(DES) from 2019 to 2022.
Chapter 3, the Drug Eluting Stents(DES) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Stents(DES) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Materials and application, with sales market share and growth rate by materials, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug Eluting Stents(DES) market forecast, by regions, materials and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Eluting Stents(DES).
Chapter 13, 14, and 15, to describe Drug Eluting Stents(DES) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Drug Eluting Stents(DES) Introduction
1.2 Market Analysis by Materials
1.2.1 Overview: Global Drug Eluting Stents(DES) Revenue by Materials: 2017 Versus 2021 Versus 2028
1.2.2 Cobalt-chromium Alloy Stents
1.2.3 Magnesium Alloy Stents
1.2.4 Tyrosine Polycarbonate Stents
1.2.5 Nitinol Stents
1.2.6 Platinum Chromium Alloy Stents
1.2.7 Stainless Steel Stents
1.2.8 Other Materials
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug Eluting Stents(DES) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Global Drug Eluting Stents(DES) Market Size & Forecast
1.4.1 Global Drug Eluting Stents(DES) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drug Eluting Stents(DES) Sales in Volume (2017-2028)
1.4.3 Global Drug Eluting Stents(DES) Price (2017-2028)
1.5 Global Drug Eluting Stents(DES) Production Capacity Analysis
1.5.1 Global Drug Eluting Stents(DES) Total Production Capacity (2017-2028)
1.5.2 Global Drug Eluting Stents(DES) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug Eluting Stents(DES) Market Drivers
1.6.2 Drug Eluting Stents(DES) Market Restraints
1.6.3 Drug Eluting Stents(DES) Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Vascular
2.1.1 Abbott Vascular Details
2.1.2 Abbott Vascular Major Business
2.1.3 Abbott Vascular Drug Eluting Stents(DES) Product and Services
2.1.4 Abbott Vascular Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Advantec Vascular
2.2.1 Advantec Vascular Details
2.2.2 Advantec Vascular Major Business
2.2.3 Advantec Vascular Drug Eluting Stents(DES) Product and Services
2.2.4 Advantec Vascular Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 B.Braun Melsengen AG
2.3.1 B.Braun Melsengen AG Details
2.3.2 B.Braun Melsengen AG Major Business
2.3.3 B.Braun Melsengen AG Drug Eluting Stents(DES) Product and Services
2.3.4 B.Braun Melsengen AG Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biosensors
2.4.1 Biosensors Details
2.4.2 Biosensors Major Business
2.4.3 Biosensors Drug Eluting Stents(DES) Product and Services
2.4.4 Biosensors Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Biotronik
2.5.1 Biotronik Details
2.5.2 Biotronik Major Business
2.5.3 Biotronik Drug Eluting Stents(DES) Product and Services
2.5.4 Biotronik Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Blue Medical
2.6.1 Blue Medical Details
2.6.2 Blue Medical Major Business
2.6.3 Blue Medical Drug Eluting Stents(DES) Product and Services
2.6.4 Blue Medical Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Boston Scientific
2.7.1 Boston Scientific Details
2.7.2 Boston Scientific Major Business
2.7.3 Boston Scientific Drug Eluting Stents(DES) Product and Services
2.7.4 Boston Scientific Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 DISA Vascular
2.8.1 DISA Vascular Details
2.8.2 DISA Vascular Major Business
2.8.3 DISA Vascular Drug Eluting Stents(DES) Product and Services
2.8.4 DISA Vascular Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Essen
2.9.1 Essen Details
2.9.2 Essen Major Business
2.9.3 Essen Drug Eluting Stents(DES) Product and Services
2.9.4 Essen Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Medtronic Vascular
2.10.1 Medtronic Vascular Details
2.10.2 Medtronic Vascular Major Business
2.10.3 Medtronic Vascular Drug Eluting Stents(DES) Product and Services
2.10.4 Medtronic Vascular Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 MicroPort Medical
2.11.1 MicroPort Medical Details
2.11.2 MicroPort Medical Major Business
2.11.3 MicroPort Medical Drug Eluting Stents(DES) Product and Services
2.11.4 MicroPort Medical Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 MIV Therapeutics
2.12.1 MIV Therapeutics Details
2.12.2 MIV Therapeutics Major Business
2.12.3 MIV Therapeutics Drug Eluting Stents(DES) Product and Services
2.12.4 MIV Therapeutics Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Orbusneich
2.13.1 Orbusneich Details
2.13.2 Orbusneich Major Business
2.13.3 Orbusneich Drug Eluting Stents(DES) Product and Services
2.13.4 Orbusneich Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Promed Medical
2.14.1 Promed Medical Details
2.14.2 Promed Medical Major Business
2.14.3 Promed Medical Drug Eluting Stents(DES) Product and Services
2.14.4 Promed Medical Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Relisys Medical
2.15.1 Relisys Medical Details
2.15.2 Relisys Medical Major Business
2.15.3 Relisys Medical Drug Eluting Stents(DES) Product and Services
2.15.4 Relisys Medical Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Reva Medical
2.16.1 Reva Medical Details
2.16.2 Reva Medical Major Business
2.16.3 Reva Medical Drug Eluting Stents(DES) Product and Services
2.16.4 Reva Medical Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Sahajanand
2.17.1 Sahajanand Details
2.17.2 Sahajanand Major Business
2.17.3 Sahajanand Drug Eluting Stents(DES) Product and Services
2.17.4 Sahajanand Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Sino Medical
2.18.1 Sino Medical Details
2.18.2 Sino Medical Major Business
2.18.3 Sino Medical Drug Eluting Stents(DES) Product and Services
2.18.4 Sino Medical Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Sorin
2.19.1 Sorin Details
2.19.2 Sorin Major Business
2.19.3 Sorin Drug Eluting Stents(DES) Product and Services
2.19.4 Sorin Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Terumo Medical
2.20.1 Terumo Medical Details
2.20.2 Terumo Medical Major Business
2.20.3 Terumo Medical Drug Eluting Stents(DES) Product and Services
2.20.4 Terumo Medical Drug Eluting Stents(DES) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drug Eluting Stents(DES) Breakdown Data by Manufacturer
3.1 Global Drug Eluting Stents(DES) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drug Eluting Stents(DES) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drug Eluting Stents(DES)
3.4 Market Concentration Rate
3.4.1 Top 3 Drug Eluting Stents(DES) Manufacturer Market Share in 2021
3.4.2 Top 6 Drug Eluting Stents(DES) Manufacturer Market Share in 2021
3.5 Global Drug Eluting Stents(DES) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drug Eluting Stents(DES) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drug Eluting Stents(DES) Market Size by Region
4.1.1 Global Drug Eluting Stents(DES) Sales in Volume by Region (2017-2028)
4.1.2 Global Drug Eluting Stents(DES) Revenue by Region (2017-2028)
4.2 North America Drug Eluting Stents(DES) Revenue (2017-2028)
4.3 Europe Drug Eluting Stents(DES) Revenue (2017-2028)
4.4 Asia-Pacific Drug Eluting Stents(DES) Revenue (2017-2028)
4.5 South America Drug Eluting Stents(DES) Revenue (2017-2028)
4.6 Middle East and Africa Drug Eluting Stents(DES) Revenue (2017-2028)
5 Market Segment by Materials
5.1 Global Drug Eluting Stents(DES) Sales in Volume by Materials (2017-2028)
5.2 Global Drug Eluting Stents(DES) Revenue by Materials (2017-2028)
5.3 Global Drug Eluting Stents(DES) Price by Materials (2017-2028)
6 Market Segment by Application
6.1 Global Drug Eluting Stents(DES) Sales in Volume by Application (2017-2028)
6.2 Global Drug Eluting Stents(DES) Revenue by Application (2017-2028)
6.3 Global Drug Eluting Stents(DES) Price by Application (2017-2028)
7 North America by Country, by Materials, and by Application
7.1 North America Drug Eluting Stents(DES) Sales by Materials (2017-2028)
7.2 North America Drug Eluting Stents(DES) Sales by Application (2017-2028)
7.3 North America Drug Eluting Stents(DES) Market Size by Country
7.3.1 North America Drug Eluting Stents(DES) Sales in Volume by Country (2017-2028)
7.3.2 North America Drug Eluting Stents(DES) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Materials, and by Application
8.1 Europe Drug Eluting Stents(DES) Sales by Materials (2017-2028)
8.2 Europe Drug Eluting Stents(DES) Sales by Application (2017-2028)
8.3 Europe Drug Eluting Stents(DES) Market Size by Country
8.3.1 Europe Drug Eluting Stents(DES) Sales in Volume by Country (2017-2028)
8.3.2 Europe Drug Eluting Stents(DES) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Materials, and by Application
9.1 Asia-Pacific Drug Eluting Stents(DES) Sales by Materials (2017-2028)
9.2 Asia-Pacific Drug Eluting Stents(DES) Sales by Application (2017-2028)
9.3 Asia-Pacific Drug Eluting Stents(DES) Market Size by Region
9.3.1 Asia-Pacific Drug Eluting Stents(DES) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drug Eluting Stents(DES) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Materials, and by Application
10.1 South America Drug Eluting Stents(DES) Sales by Materials (2017-2028)
10.2 South America Drug Eluting Stents(DES) Sales by Application (2017-2028)
10.3 South America Drug Eluting Stents(DES) Market Size by Country
10.3.1 South America Drug Eluting Stents(DES) Sales in Volume by Country (2017-2028)
10.3.2 South America Drug Eluting Stents(DES) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Materials, and by Application
11.1 Middle East & Africa Drug Eluting Stents(DES) Sales by Materials (2017-2028)
11.2 Middle East & Africa Drug Eluting Stents(DES) Sales by Application (2017-2028)
11.3 Middle East & Africa Drug Eluting Stents(DES) Market Size by Country
11.3.1 Middle East & Africa Drug Eluting Stents(DES) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drug Eluting Stents(DES) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drug Eluting Stents(DES) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drug Eluting Stents(DES)
12.3 Drug Eluting Stents(DES) Production Process
12.4 Drug Eluting Stents(DES) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drug Eluting Stents(DES) Typical Distributors
13.3 Drug Eluting Stents(DES) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Eluting Stents(DES) Revenue by Materials, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drug Eluting Stents(DES) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Abbott Vascular Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Vascular Major Business
Table 5. Abbott Vascular Drug Eluting Stents(DES) Product and Services
Table 6. Abbott Vascular Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Advantec Vascular Basic Information, Manufacturing Base and Competitors
Table 8. Advantec Vascular Major Business
Table 9. Advantec Vascular Drug Eluting Stents(DES) Product and Services
Table 10. Advantec Vascular Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. B.Braun Melsengen AG Basic Information, Manufacturing Base and Competitors
Table 12. B.Braun Melsengen AG Major Business
Table 13. B.Braun Melsengen AG Drug Eluting Stents(DES) Product and Services
Table 14. B.Braun Melsengen AG Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Biosensors Basic Information, Manufacturing Base and Competitors
Table 16. Biosensors Major Business
Table 17. Biosensors Drug Eluting Stents(DES) Product and Services
Table 18. Biosensors Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Biotronik Basic Information, Manufacturing Base and Competitors
Table 20. Biotronik Major Business
Table 21. Biotronik Drug Eluting Stents(DES) Product and Services
Table 22. Biotronik Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Blue Medical Basic Information, Manufacturing Base and Competitors
Table 24. Blue Medical Major Business
Table 25. Blue Medical Drug Eluting Stents(DES) Product and Services
Table 26. Blue Medical Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 28. Boston Scientific Major Business
Table 29. Boston Scientific Drug Eluting Stents(DES) Product and Services
Table 30. Boston Scientific Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. DISA Vascular Basic Information, Manufacturing Base and Competitors
Table 32. DISA Vascular Major Business
Table 33. DISA Vascular Drug Eluting Stents(DES) Product and Services
Table 34. DISA Vascular Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Essen Basic Information, Manufacturing Base and Competitors
Table 36. Essen Major Business
Table 37. Essen Drug Eluting Stents(DES) Product and Services
Table 38. Essen Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Medtronic Vascular Basic Information, Manufacturing Base and Competitors
Table 40. Medtronic Vascular Major Business
Table 41. Medtronic Vascular Drug Eluting Stents(DES) Product and Services
Table 42. Medtronic Vascular Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 44. MicroPort Medical Major Business
Table 45. MicroPort Medical Drug Eluting Stents(DES) Product and Services
Table 46. MicroPort Medical Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. MIV Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. MIV Therapeutics Major Business
Table 49. MIV Therapeutics Drug Eluting Stents(DES) Product and Services
Table 50. MIV Therapeutics Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Orbusneich Basic Information, Manufacturing Base and Competitors
Table 52. Orbusneich Major Business
Table 53. Orbusneich Drug Eluting Stents(DES) Product and Services
Table 54. Orbusneich Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Promed Medical Basic Information, Manufacturing Base and Competitors
Table 56. Promed Medical Major Business
Table 57. Promed Medical Drug Eluting Stents(DES) Product and Services
Table 58. Promed Medical Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Relisys Medical Basic Information, Manufacturing Base and Competitors
Table 60. Relisys Medical Major Business
Table 61. Relisys Medical Drug Eluting Stents(DES) Product and Services
Table 62. Relisys Medical Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Reva Medical Basic Information, Manufacturing Base and Competitors
Table 64. Reva Medical Major Business
Table 65. Reva Medical Drug Eluting Stents(DES) Product and Services
Table 66. Reva Medical Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Sahajanand Basic Information, Manufacturing Base and Competitors
Table 68. Sahajanand Major Business
Table 69. Sahajanand Drug Eluting Stents(DES) Product and Services
Table 70. Sahajanand Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Sino Medical Basic Information, Manufacturing Base and Competitors
Table 72. Sino Medical Major Business
Table 73. Sino Medical Drug Eluting Stents(DES) Product and Services
Table 74. Sino Medical Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Sorin Basic Information, Manufacturing Base and Competitors
Table 76. Sorin Major Business
Table 77. Sorin Drug Eluting Stents(DES) Product and Services
Table 78. Sorin Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Terumo Medical Basic Information, Manufacturing Base and Competitors
Table 80. Terumo Medical Major Business
Table 81. Terumo Medical Drug Eluting Stents(DES) Product and Services
Table 82. Terumo Medical Drug Eluting Stents(DES) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Drug Eluting Stents(DES) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 84. Global Drug Eluting Stents(DES) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Drug Eluting Stents(DES), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Drug Eluting Stents(DES) Production Capacity by Company, (K Units): 2020 VS 2021
Table 87. Head Office and Drug Eluting Stents(DES) Production Site of Key Manufacturer
Table 88. Drug Eluting Stents(DES) New Entrant and Capacity Expansion Plans
Table 89. Drug Eluting Stents(DES) Mergers & Acquisitions in the Past Five Years
Table 90. Global Drug Eluting Stents(DES) Sales by Region (2017-2022) & (K Units)
Table 91. Global Drug Eluting Stents(DES) Sales by Region (2023-2028) & (K Units)
Table 92. Global Drug Eluting Stents(DES) Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Drug Eluting Stents(DES) Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 95. Global Drug Eluting Stents(DES) Sales by Materials (2023-2028) & (K Units)
Table 96. Global Drug Eluting Stents(DES) Revenue by Materials (2017-2022) & (USD Million)
Table 97. Global Drug Eluting Stents(DES) Revenue by Materials (2023-2028) & (USD Million)
Table 98. Global Drug Eluting Stents(DES) Price by Materials (2017-2022) & (USD/Unit)
Table 99. Global Drug Eluting Stents(DES) Price by Materials (2023-2028) & (USD/Unit)
Table 100. Global Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 101. Global Drug Eluting Stents(DES) Sales by Application (2023-2028) & (K Units)
Table 102. Global Drug Eluting Stents(DES) Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Drug Eluting Stents(DES) Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Drug Eluting Stents(DES) Price by Application (2017-2022) & (USD/Unit)
Table 105. Global Drug Eluting Stents(DES) Price by Application (2023-2028) & (USD/Unit)
Table 106. North America Drug Eluting Stents(DES) Sales by Country (2017-2022) & (K Units)
Table 107. North America Drug Eluting Stents(DES) Sales by Country (2023-2028) & (K Units)
Table 108. North America Drug Eluting Stents(DES) Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Drug Eluting Stents(DES) Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 111. North America Drug Eluting Stents(DES) Sales by Materials (2023-2028) & (K Units)
Table 112. North America Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 113. North America Drug Eluting Stents(DES) Sales by Application (2023-2028) & (K Units)
Table 114. Europe Drug Eluting Stents(DES) Sales by Country (2017-2022) & (K Units)
Table 115. Europe Drug Eluting Stents(DES) Sales by Country (2023-2028) & (K Units)
Table 116. Europe Drug Eluting Stents(DES) Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Drug Eluting Stents(DES) Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 119. Europe Drug Eluting Stents(DES) Sales by Materials (2023-2028) & (K Units)
Table 120. Europe Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 121. Europe Drug Eluting Stents(DES) Sales by Application (2023-2028) & (K Units)
Table 122. Asia-Pacific Drug Eluting Stents(DES) Sales by Region (2017-2022) & (K Units)
Table 123. Asia-Pacific Drug Eluting Stents(DES) Sales by Region (2023-2028) & (K Units)
Table 124. Asia-Pacific Drug Eluting Stents(DES) Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Drug Eluting Stents(DES) Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 127. Asia-Pacific Drug Eluting Stents(DES) Sales by Materials (2023-2028) & (K Units)
Table 128. Asia-Pacific Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 129. Asia-Pacific Drug Eluting Stents(DES) Sales by Application (2023-2028) & (K Units)
Table 130. South America Drug Eluting Stents(DES) Sales by Country (2017-2022) & (K Units)
Table 131. South America Drug Eluting Stents(DES) Sales by Country (2023-2028) & (K Units)
Table 132. South America Drug Eluting Stents(DES) Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Drug Eluting Stents(DES) Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 135. South America Drug Eluting Stents(DES) Sales by Materials (2023-2028) & (K Units)
Table 136. South America Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 137. South America Drug Eluting Stents(DES) Sales by Application (2023-2028) & (K Units)
Table 138. Middle East & Africa Drug Eluting Stents(DES) Sales by Region (2017-2022) & (K Units)
Table 139. Middle East & Africa Drug Eluting Stents(DES) Sales by Region (2023-2028) & (K Units)
Table 140. Middle East & Africa Drug Eluting Stents(DES) Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Drug Eluting Stents(DES) Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Drug Eluting Stents(DES) Sales by Materials (2017-2022) & (K Units)
Table 143. Middle East & Africa Drug Eluting Stents(DES) Sales by Materials (2023-2028) & (K Units)
Table 144. Middle East & Africa Drug Eluting Stents(DES) Sales by Application (2017-2022) & (K Units)
Table 145. Middle East & Africa Drug Eluting Stents(DES) Sales by Application (2023-2028) & (K Units)
Table 146. Drug Eluting Stents(DES) Raw Material
Table 147. Key Manufacturers of Drug Eluting Stents(DES) Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Drug Eluting Stents(DES) Typical Distributors
Table 151. Drug Eluting Stents(DES) Typical Customers
List of Figures
Figure 1. Drug Eluting Stents(DES) Picture
Figure 2. Global Drug Eluting Stents(DES) Revenue Market Share by Materials in 2021
Figure 3. Cobalt-chromium Alloy Stents
Figure 4. Magnesium Alloy Stents
Figure 5. Tyrosine Polycarbonate Stents
Figure 6. Nitinol Stents
Figure 7. Platinum Chromium Alloy Stents
Figure 8. Stainless Steel Stents
Figure 9. Other Materials
Figure 10. Global Drug Eluting Stents(DES) Revenue Market Share by Application in 2021
Figure 11. Coronary Heart Disease
Figure 12. Clinical
Figure 13. Global Drug Eluting Stents(DES) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Drug Eluting Stents(DES) Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Drug Eluting Stents(DES) Sales (2017-2028) & (K Units)
Figure 16. Global Drug Eluting Stents(DES) Price (2017-2028) & (USD/Unit)
Figure 17. Global Drug Eluting Stents(DES) Production Capacity (2017-2028) & (K Units)
Figure 18. Global Drug Eluting Stents(DES) Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Drug Eluting Stents(DES) Market Drivers
Figure 20. Drug Eluting Stents(DES) Market Restraints
Figure 21. Drug Eluting Stents(DES) Market Trends
Figure 22. Global Drug Eluting Stents(DES) Sales Market Share by Manufacturer in 2021
Figure 23. Global Drug Eluting Stents(DES) Revenue Market Share by Manufacturer in 2021
Figure 24. Drug Eluting Stents(DES) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Drug Eluting Stents(DES) Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Drug Eluting Stents(DES) Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Drug Eluting Stents(DES) Sales Market Share by Region (2017-2028)
Figure 28. Global Drug Eluting Stents(DES) Revenue Market Share by Region (2017-2028)
Figure 29. North America Drug Eluting Stents(DES) Revenue (2017-2028) & (USD Million)
Figure 30. Europe Drug Eluting Stents(DES) Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Drug Eluting Stents(DES) Revenue (2017-2028) & (USD Million)
Figure 32. South America Drug Eluting Stents(DES) Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Drug Eluting Stents(DES) Revenue (2017-2028) & (USD Million)
Figure 34. Global Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2028)
Figure 35. Global Drug Eluting Stents(DES) Revenue Market Share by Materials (2017-2028)
Figure 36. Global Drug Eluting Stents(DES) Price by Materials (2017-2028) & (USD/Unit)
Figure 37. Global Drug Eluting Stents(DES) Sales Market Share by Application (2017-2028)
Figure 38. Global Drug Eluting Stents(DES) Revenue Market Share by Application (2017-2028)
Figure 39. Global Drug Eluting Stents(DES) Price by Application (2017-2028) & (USD/Unit)
Figure 40. North America Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2028)
Figure 41. North America Drug Eluting Stents(DES) Sales Market Share by Application (2017-2028)
Figure 42. North America Drug Eluting Stents(DES) Sales Market Share by Country (2017-2028)
Figure 43. North America Drug Eluting Stents(DES) Revenue Market Share by Country (2017-2028)
Figure 44. United States Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2028)
Figure 48. Europe Drug Eluting Stents(DES) Sales Market Share by Application (2017-2028)
Figure 49. Europe Drug Eluting Stents(DES) Sales Market Share by Country (2017-2028)
Figure 50. Europe Drug Eluting Stents(DES) Revenue Market Share by Country (2017-2028)
Figure 51. Germany Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Drug Eluting Stents(DES) Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Drug Eluting Stents(DES) Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Drug Eluting Stents(DES) Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Drug Eluting Stents(DES) Revenue Market Share by Region (2017-2028)
Figure 60. China Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2028)
Figure 67. South America Drug Eluting Stents(DES) Sales Market Share by Application (2017-2028)
Figure 68. South America Drug Eluting Stents(DES) Sales Market Share by Country (2017-2028)
Figure 69. South America Drug Eluting Stents(DES) Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Drug Eluting Stents(DES) Sales Market Share by Materials (2017-2028)
Figure 73. Middle East & Africa Drug Eluting Stents(DES) Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Drug Eluting Stents(DES) Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Drug Eluting Stents(DES) Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Drug Eluting Stents(DES) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Drug Eluting Stents(DES) in 2021
Figure 81. Manufacturing Process Analysis of Drug Eluting Stents(DES)
Figure 82. Drug Eluting Stents(DES) Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
